000 01526 a2200445 4500
005 20250514010539.0
264 0 _c20011204
008 200112s 0 0 eng d
022 _a1061-4036
024 7 _a10.1038/ng731
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMacDonald, T J
245 0 0 _aExpression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.
_h[electronic resource]
260 _bNature genetics
_cOct 2001
300 _a143-52 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aButadienes
_xpharmacology
650 0 4 _aEnzyme Activation
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aGene Expression Profiling
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMAP Kinase Signaling System
650 0 4 _aMedulloblastoma
_xgenetics
650 0 4 _aMitogen-Activated Protein Kinases
_xantagonists & inhibitors
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNitriles
_xpharmacology
650 0 4 _aPhenotype
650 0 4 _aReceptor, Platelet-Derived Growth Factor alpha
_xgenetics
700 1 _aBrown, K M
700 1 _aLaFleur, B
700 1 _aPeterson, K
700 1 _aLawlor, C
700 1 _aChen, Y
700 1 _aPacker, R J
700 1 _aCogen, P
700 1 _aStephan, D A
773 0 _tNature genetics
_gvol. 29
_gno. 2
_gp. 143-52
856 4 0 _uhttps://doi.org/10.1038/ng731
_zAvailable from publisher's website
999 _c11468032
_d11468032